AutoPulse Compared With Manual Technique for OHCA Patients on Outcome and CPR Process.
Use of a Load Distributing Band Device Compared With Manual Technique for Out of Hospital Cardiac Arrest Patients on Outcome and Cardiopulmonary Resuscitation Process. A Retrospective Clinical Study.
1 other identifier
observational
3,250
1 country
1
Brief Summary
The AutoPulse Resuscitation System Model 100 (ZOLL Medical Corporation, Chelmsford, MA, US) ZOLL has been used as a standard treatment for a number of subjects in this trial and granted CE marking for Europe in November of 2003. The AutoPulse device is an automated, portable, battery-powered, load-band-distributing (LDB), chest compression device, which provides chest compressions as an adjunct to performing manual cardiopulmonary resuscitation (CPR). Use of the device is intended to provide consistent chest compressions without interruption to a victim of out-of-hospital cardiac arrest (OOHCA), to reduce the impact of rescuer fatigue due to application of manual CPR, and to enable rescuers to address additional patient needs. In the present study investigators will compare electronic data generated during cardiopulmonary resuscitation stored in the different multimonitores between LDB and manual chest compressions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2020
CompletedStudy Start
First participant enrolled
December 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2020
CompletedFirst Posted
Study publicly available on registry
December 10, 2020
CompletedDecember 14, 2020
December 1, 2020
Same day
December 3, 2020
December 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
The primary endpoint is OOHCA patient survival to hospital discharge
through study completion, an average of 1 year
Secondary Outcomes (2)
Short time survival
through study completion, an average of 1 year
CPR process outcomes
through study completion, an average of 1 year
Study Arms (2)
Mechanical chest compression
Patients recieving LDB CPR
Manual chest compressions
Patients recieving manual CPR
Interventions
A band circumflex of the chest that provide chest cage compressions.
Eligibility Criteria
Patients in cardiac arrest treated by the EMS at the different sites.
You may not qualify if:
- Wards of the state
- Prisoner
- Do Not Attempt to Resuscitate (DNAR) orders
- Patients whose chest circumference is too big (\> 130 cm)
- Patients whose chest circumference is too small (\< 75 cm)
- Patients whose weight is greater than 150 Kg.
- CPR device other than LDB device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lars Wiklead
- Jon Erik Steen Hansencollaborator
- Unai Irusta Zarandonacollaborator
- Elisabete Aramendicollaborator
- Erik Alonsocollaborator
- Simone Savastanocollaborator
- Enrico Baldicollaborator
- Alessandra Palocollaborator
Study Sites (1)
Central Hospital Vestfold
Tønsberg, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars Wik, MD, PhD
Oslo University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
December 3, 2020
First Posted
December 10, 2020
Study Start
December 3, 2020
Primary Completion
December 3, 2020
Study Completion
December 3, 2020
Last Updated
December 14, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share